FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293727720> ?p ?o ?g. }

• W4293727720 endingPage "1394" @default.
• W4293727720 startingPage "1394" @default.
• W4293727720 abstract "Emergence of mutations is an inherent property of RNA viruses with several implications for their replication, pathogenesis, and evolutionary adaptation. Oral poliovirus vaccine (OPV), developed by Albert Sabin, is composed of live attenuated polioviruses of three serotypes that can revert to neurovirulence during replication in cell culture and in vaccine recipients. Recently, a new modified variant of Sabin 2 virus was developed by introducing changes in its genome, making it more genetically stable to prevent the reversion. The new strain was used to manufacture novel OPV2 (nOPV2), which was approved by the World Health Organization for emergency use to stop outbreaks caused by circulating vaccine-derived poliovirus (cVDPV2). Manufacture of this improved vaccine requires close attention to the genetic heterogenicity to ensure that the levels of the undesirable mutations are limited. Preliminary studies using whole-genome Illumina sequencing (NGS) identified several genomic sites where mutations tend to occur with regularity. They include VP1-I143T amino acid change at the secondary attenuation site; VP1-N171D, a substitution that modestly increases neurovirulence in mice; and VP1-E295K, which may reduce the immunogenicity of the nOPV2. Therefore, to ensure the molecular consistency of vaccine batches, the content of these mutants must be quantified and kept within specifications. To do this, we have developed quantitative, multiplex, one-step reverse-transcriptase polymerase chain reactions (qmosRT-PCRs) as simple methods for quantification of these mutations. Each method uses specific short TaqMan probes with different dyes for the analysis of both mutants and non-mutants in the same sample. The quantification is done using calibration curves developed using validated reference materials. To evaluate the sensitivity and the linearity of the qmosRT-PCR method, the mutant viruses were spiked in non-mutant viruses, and nOPV2 batches were used to validate the method. The spiked samples and the nOPV2 batches were analyzed by qmosRT-PCR and NGS assays. The results showed that qmosRT-PCR is sensitive enough to detect around 1% of mutants. The percentages of mutants determined by qmosRT-PCR correlate well with the results of the NGS. Further, the analysis of the nOPV2 batches showed that the results of qmosRT-PCR correlated well with the results of NGS. In conclusion, the qmosRT-PCR is a specific, sensitive, and linear method. It could be used for quality control of the nOPV2 batches." @default.
• W4293727720 created "2022-08-31" @default.
• W4293727720 creator A5005938301 @default.
• W4293727720 creator A5033214540 @default.
• W4293727720 creator A5036970296 @default.
• W4293727720 creator A5049688300 @default.
• W4293727720 creator A5052683598 @default.
• W4293727720 creator A5075414157 @default.
• W4293727720 creator A5084525004 @default.
• W4293727720 creator A5085074509 @default.
• W4293727720 date "2022-08-25" @default.
• W4293727720 modified "2023-09-25" @default.
• W4293727720 title "Quantitative RT-PCR Assays for Quantification of Undesirable Mutants in the Novel Type 2 Oral Poliovirus Vaccine" @default.
• W4293727720 cites W1670248086 @default.
• W4293727720 cites W1973320835 @default.
• W4293727720 cites W1977554521 @default.
• W4293727720 cites W1979537384 @default.
• W4293727720 cites W1983764014 @default.
• W4293727720 cites W2012953421 @default.
• W4293727720 cites W2032360710 @default.
• W4293727720 cites W2033630039 @default.
• W4293727720 cites W2042148102 @default.
• W4293727720 cites W2044967254 @default.
• W4293727720 cites W2047976861 @default.
• W4293727720 cites W2050956922 @default.
• W4293727720 cites W2063911954 @default.
• W4293727720 cites W2067146710 @default.
• W4293727720 cites W2082588492 @default.
• W4293727720 cites W2096842407 @default.
• W4293727720 cites W2102060315 @default.
• W4293727720 cites W2116902410 @default.
• W4293727720 cites W2120458284 @default.
• W4293727720 cites W2124934598 @default.
• W4293727720 cites W2129812184 @default.
• W4293727720 cites W2136181739 @default.
• W4293727720 cites W2141397924 @default.
• W4293727720 cites W2515706651 @default.
• W4293727720 cites W2598379945 @default.
• W4293727720 cites W2735088147 @default.
• W4293727720 cites W2735657752 @default.
• W4293727720 cites W2781617550 @default.
• W4293727720 cites W2889458573 @default.
• W4293727720 cites W2982344123 @default.
• W4293727720 cites W2986629155 @default.
• W4293727720 cites W3012215772 @default.
• W4293727720 cites W3019697184 @default.
• W4293727720 cites W3022695806 @default.
• W4293727720 cites W3167550623 @default.
• W4293727720 cites W4211012480 @default.
• W4293727720 cites W4229698432 @default.
• W4293727720 cites W2471031044 @default.
• W4293727720 doi "https://doi.org/10.3390/vaccines10091394" @default.
• W4293727720 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36146473" @default.
• W4293727720 hasPublicationYear "2022" @default.
• W4293727720 type Work @default.
• W4293727720 citedByCount "0" @default.
• W4293727720 crossrefType "journal-article" @default.
• W4293727720 hasAuthorship W4293727720A5005938301 @default.
• W4293727720 hasAuthorship W4293727720A5033214540 @default.
• W4293727720 hasAuthorship W4293727720A5036970296 @default.
• W4293727720 hasAuthorship W4293727720A5049688300 @default.
• W4293727720 hasAuthorship W4293727720A5052683598 @default.
• W4293727720 hasAuthorship W4293727720A5075414157 @default.
• W4293727720 hasAuthorship W4293727720A5084525004 @default.
• W4293727720 hasAuthorship W4293727720A5085074509 @default.
• W4293727720 hasBestOaLocation W42937277201 @default.
• W4293727720 hasConcept C104317684 @default.
• W4293727720 hasConcept C141231307 @default.
• W4293727720 hasConcept C143065580 @default.
• W4293727720 hasConcept C143660080 @default.
• W4293727720 hasConcept C159047783 @default.
• W4293727720 hasConcept C159654299 @default.
• W4293727720 hasConcept C2522874641 @default.
• W4293727720 hasConcept C2779631682 @default.
• W4293727720 hasConcept C2780868878 @default.
• W4293727720 hasConcept C2781188995 @default.
• W4293727720 hasConcept C49105822 @default.
• W4293727720 hasConcept C54355233 @default.
• W4293727720 hasConcept C54602769 @default.
• W4293727720 hasConcept C60987743 @default.
• W4293727720 hasConcept C70721500 @default.
• W4293727720 hasConcept C86803240 @default.
• W4293727720 hasConceptScore W4293727720C104317684 @default.
• W4293727720 hasConceptScore W4293727720C141231307 @default.
• W4293727720 hasConceptScore W4293727720C143065580 @default.
• W4293727720 hasConceptScore W4293727720C143660080 @default.
• W4293727720 hasConceptScore W4293727720C159047783 @default.
• W4293727720 hasConceptScore W4293727720C159654299 @default.
• W4293727720 hasConceptScore W4293727720C2522874641 @default.
• W4293727720 hasConceptScore W4293727720C2779631682 @default.
• W4293727720 hasConceptScore W4293727720C2780868878 @default.
• W4293727720 hasConceptScore W4293727720C2781188995 @default.
• W4293727720 hasConceptScore W4293727720C49105822 @default.
• W4293727720 hasConceptScore W4293727720C54355233 @default.
• W4293727720 hasConceptScore W4293727720C54602769 @default.
• W4293727720 hasConceptScore W4293727720C60987743 @default.
• W4293727720 hasConceptScore W4293727720C70721500 @default.
• W4293727720 hasConceptScore W4293727720C86803240 @default.

• next